Research Article
OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
Table 4
HR for prognosis of NSCLC patients that underwent chemotherapy.
| Factors | HR | 95% CI | |
| Chemotherapy response | | | | Well response | 1 | | | Poor response | 2.87 | 1.54–4.89 | <0.001 | Differentiation | | | | Well + moderate | 1 | | | Poor | 2.02 | 1.13–3.62 | <0.001 | OPN −443C>T | | | | TT | 1 | | | CC | 2.46 | 1.92–4.83 | <0.001 |
|
|